RYTM – rhythm pharmaceuticals, inc. (US:NASDAQ)

News

Rhythm Pharmaceuticals (RYTM) had its "buy" rating reaffirmed by Jefferies Financial Group Inc..
Rhythm Pharmaceuticals price target lowered to $110 from $125 at H.C. Wainwright [Yahoo! Finance]
Rhythm Pharmaceuticals (RYTM) had its price target lowered by Canaccord Genuity Group Inc. from $141.00 to $140.00. They now have a "buy" rating on the stock.
Rhythm Pharmaceuticals (RYTM) had its price target lowered by HC Wainwright from $125.00 to $110.00. They now have a "buy" rating on the stock.
A Look At Rhythm Pharmaceuticals (RYTM) Valuation After Recent Pullback In Share Price [Yahoo! Finance]
Show more
Live Event: Join our next subscriber-only event: "The Data Driven Investor"
Register for our next upcoming LIVE training session, which will be hosted on Tuesday April 24th at 08:00 PM EST (New York Time).
Get your questions answered during the Q & A session.
For any support questions, contact our team: support@newsquantified.com